Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04371146Completed
Randomised, double-blind trial comparing Methylphenidate, Reboxetine and Placebo (3 arms). Primary endpoints: Response time data and Choice data. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04371146.